Gut bacteria after pancreatic surgery trial
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial studies whether a probiotic called Clostridium butyricum can help recovery after pancreatic surgery. It is for patients having a Whipple procedure for tumors near the pancreas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are scheduled for a Whipple surgery (pancreaticoduodenectomy)
- You have a tumor near the pancreas that is benign (non-cancer) or malignant (cancer)
- You are having surgery first, without any chemo or radiation before
- You do not have lactose intolerance
- You have not taken the probiotic Clostridium butyricum before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at gut bacteria in people who had Whipple surgery for pancreatic cancer and in healthy volunteers. It aims to understand how the microbiome changes after surgery.
This study looks at differences in microbes (tiny organisms) using previously collected pancreatic tissue samples. It may help doctors understand how the microbiome relates to pancreatic diseases like pancreatic cancer.
This study looks at the bacteria living in your gut and pancreas to understand how they might affect pancreatic cancer and precancerous changes. It is for people who are already scheduled for an endoscopic procedure to look at or treat a pancreatic lesion.
This study looks at how changing the gut microbiome (gut bacteria) may help people with pancreatic cancer regain strength and slow or reverse cancer-related weight loss (cachexia). It also studies gut bacteria differences in people with pancreatic cancer who are losing weight versus those whose weight is stable, and in healthy volunteers.
This Phase 2 study tests whether changing the gut microbiome (the gut’s helpful bacteria) and giving pembrolizumab after chemotherapy can improve outcomes for people with operable pancreatic cancer. It aims to see if this approach can boost the immune system after standard treatment and help reduce cancer returning.
This trial studies bacteria found inside pancreatic tumors to see if they can help diagnose or predict the course of the disease. You may be eligible if you have a suspected pancreatic cancer and need a special biopsy (EUS-FNB).
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.